Does verapamil cause cough?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Verapamil Cause Cough?

No, verapamil does not cause cough as a recognized side effect. Unlike ACE inhibitors which are well-established causes of chronic cough, verapamil (a calcium channel blocker) is not associated with cough and has even been studied as a potential treatment option for ACE inhibitor-induced cough.

Key Evidence

Verapamil vs. ACE Inhibitors

The available guidelines and evidence clearly distinguish between drug classes that cause cough:

  • ACE inhibitors are well-documented causes of chronic cough 1, 2, 1, 2. The mechanism involves accumulation of bradykinin and substance P when ACE is inhibited, leading to cough in 5-35% of patients.

  • Calcium channel blockers like verapamil do NOT share this mechanism and are actually mentioned as alternative agents when ACE inhibitor cough occurs 2.

Verapamil as Treatment for ACE Inhibitor Cough

Notably, the ACCP guidelines specifically list amlodipine and nifedipine (other calcium channel blockers) as potential treatments to suppress ACE inhibitor-induced cough 2. This demonstrates that calcium channel blockers as a class are not associated with causing cough.

Important Caveats About Verapamil

While verapamil doesn't cause cough, it can cause respiratory symptoms in specific contexts:

Bronchospasm Risk (Not Cough)

  • Inhaled verapamil can cause bronchoconstriction in asthmatic patients at doses ≥20 mg, associated with cough or wheezing 3, 4. This is a bronchospastic reaction, not a chronic cough syndrome.

  • One case report documented acute asthma attacks with sustained-release oral verapamil in an asymptomatic asthmatic patient 3, but this represents bronchospasm rather than isolated cough.

  • The FDA label notes that verapamil "does not induce bronchoconstriction" in general use 5, though caution is warranted in severe asthmatics.

Clinical Bottom Line

If a patient on verapamil develops chronic cough, look for other causes (GERD, postnasal drip, asthma, other medications) rather than attributing it to verapamil. The drug-induced cough guidelines 6 recommend evaluating for drug-induced cough in unexplained cases, but verapamil is not listed among the culprit medications—ACE inhibitors, beta-blockers, inhaled medications, nitrofurantoin, and mycophenolate are the primary offenders.

Do not discontinue verapamil for isolated cough without investigating other etiologies first, as this would remove an effective cardiovascular medication for an unrelated problem.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.